Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-06 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |